GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 20.30
0.00 (0.00%)
Nov 13, 2026, 1:17 PM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.28 billion as of November 13, 2026. It is the 27,571st most valuable company in the world and the 1,546th biggest in Taiwan. Its market cap has decreased by 4.70% in one year.
Market Cap
2.28B
Enterprise Value
2.23B
Revenue
19.51M
Global Rank
Country Rank
#1,546 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.28B, an increase of 51.52%. That is a compound annual growth rate of 2.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.28B | -18.02% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shine-On BioMedical | 2.96B |
| BioGend Therapeutics | 2.74B |
| Intech Biopharm | 2.74B |
| Senhwa Biosciences | 2.65B |
| Energenesis Biomedical CO.,LTD. | 2.64B |
| Chunghwa Chemical Synthesis & Biotech | 2.38B |
| Syngen Biotech | 2.18B |
| Taiwan Bio Therapeutics | 2.17B |